PT143 Outcomes of oral Anticoagulation management post Anterior STEMI in the Primary PCI era

O ST E R A B ST R A C T S Basal characteristics, group A and B, respectively n (%): age 61,6 11,2 vs 59 14,5; masculine sex 28(85) vs 18(86); diabetes 9(27) vs 7(33); prior infarct 7(21) vs 5(24); prior revascularization 5(15) vs 3(14); LVEF 39,6 16 vs 46,5 21; anterior infarct 10(30) vs 9(43); anterior descending artery affected 18(54) vs 19(90); presence of collateral circulation 10(30) vs 3(14); use of IABP 11(33) vs 3(14); use of GP IIbIIIa 10(30) vs 2(9); use of tromboaspiration 3(9) vs 2(9); millimeters of stent implanted 46 32 vs 71,5 32; implant of drug eluting stents 5(15) vs 8(38); dye material 263,1 121 vs 305,2 93 ml; time of fluoroscopy 25,3 21,5 vs 23,7 16,4 minutes. Results: Group A and B n (%), respectively: mortality intrahospitalary 7(21) vs 2(9); reinfarct 0 vs 2 (9); early occlusion coronary 1(3) vs 2(9); renal insufficiency pos PCI 0 vs 1(5). In the average follow-up to 20 months of the 96% population there demonstrated, group A and B n (%), respectively: total mortality to 6 months 10(30) vs 4(19); cardiac mortality to 6 months 10(30) vs 2(9) p1⁄40,05; reinfarct 1(4) vs 0; need of coronary revascularization 7(27) vs 1(5) and events combined of cardiac death, reinfarct and new revascularization 18(54) vs 5(21) p1⁄40,02. Conclusion: The complete coronary revascularization in the same session in STEMI and cardiac failure and MVD, demonstrated to be more favorable in terms of total mortality and adverse major combined events that the PCI only of the culprit vessel. Disclosure of Interest: None Declared